LIFECORE BIOMEDICAL INC (LCBM) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 39 transactions totaling $19.1M, demonstrating a bearish sentiment with -$17.7M in net insider flow. The most recent transaction on Mar 20, 2008 involved a sale of 839,500 shares valued at $14.3M.
No significant insider buying has been recorded for LCBM in the recent period.
No significant insider selling has been recorded for LCBM in the recent period.
Based on recent SEC filings, insider sentiment for LCBM is bearish with an Insider Alignment Score of 4/100 and a net flow of -$17.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at LIFECORE BIOMEDICAL INC (LCBM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading LCBM stock, having executed 39 transactions in the past 90 days. The most active insider is John E. Runnells (Executive), who has made 12 transactions totaling $19.1M.
Get notified when executives and directors at LCBM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 20, 2008 | E. Runnells John | Executive | Sale | 839,500 | $17.00 | $14.3M | Large |
| Mar 20, 2008 | E. Runnells John | Executive | Sale | 1,800 | $17.00 | $30.6K | |
| Mar 20, 2008 | J. Allingham Dennis | Executive | Tender | 21,600 | $17.00 | $367.2K | |
| Mar 20, 2008 | H. Garrett Thomas | Executive | Tender | 11,544 | $17.00 | $196.2K | |
| Mar 20, 2008 | G. Hall James | Executive | Tender | 2,356 | $17.00 | $40.1K | |
| Mar 20, 2008 | D. Hiebert Larry | Executive | Tender | 8,618 | $17.00 | $146.5K | |
| Mar 20, 2008 | M. Noel David | Executive | Tender | 8,618 | $17.00 | $146.5K | |
| Mar 20, 2008 | W. Perkins Richard | Executive | Tender | 6,000 | $17.00 | $102.0K | |
| Mar 20, 2008 | W. Perkins Richard | Executive | Tender | 10,000 | $17.00 | $170.0K | |
| Mar 20, 2008 | W. Perkins Richard | Executive | Tender | 139,000 | $17.00 | $2.4M | Large |
| Mar 20, 2008 | W. Perkins Richard | Executive | Tender | 7,500 | $17.00 | $127.5K | |
| Mar 20, 2008 | Thacker Kipling | Executive | Tender | 25,259 | $17.00 | $429.4K | |
| Mar 20, 2008 | Thacker Kipling | Executive | Tender | 650 | $17.00 | $11.1K | |
| Nov 6, 2007 | L. Carter Orwin | Executive | Option Exercise | 30,000 | $7.19 | $215.7K | |
| Nov 6, 2007 | L. Carter Orwin | Executive | Option Exercise | 30,000 | $6.66 | $199.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 10 | $18.4M | 74.5% |
Tender(U) | 11 | $4.1M | 16.6% |
Exercise(M) | 6 | $1.4M | 5.6% |
Purchase(P) | 2 | $725.6K | 2.9% |
Payment(F) | 4 | $63.7K | 0.3% |
Award(A) | 5 | $12.0K | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at LIFECORE BIOMEDICAL INC has increased, with 11 insiders executing 39 transactions across all time. Total sales of $18.4M significantly outpace purchases of $725.6K, resulting in a net outflow of $17.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.